PineBridge Investments’s Edwards Lifesciences EW Stock Holding History

PineBridge Investments’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$672K	Buy	8,390 +4,648	+124%	+$383K	0.01%	413
2025 Q4	$319K	Sell	3,742 -191,971	-98%	-$15.8M	﹤0.01%	501
2025 Q3	$15.2M	Buy	195,713 +34,155	+21%	+$2.67M	0.11%	150
2025 Q2	$12.6M	Sell	161,558 -50,129	-24%	-$3.74M	0.1%	191
2025 Q1	$15.3M	Buy	+211,687	New	+$15.2M	0.12%	167
2024 Q4	–	Sell	-46,360	Closed	-$3.06M	–	727
2024 Q3	$3.06M	Buy	46,360 +2,632	+6%	+$191K	0.02%	380
2024 Q2	$4.04M	Sell	43,728 -97,598	-69%	-$8.64M	0.03%	330
2024 Q1	$13.5M	Buy	141,326 +76,235	+117%	+$6.4M	0.11%	197
2023 Q4	$4.96M	Sell	65,091 -96,612	-60%	-$6.72M	0.05%	292
2023 Q3	$11.2M	Buy	161,703 +1,627	+1%	+$131K	0.12%	157
2023 Q2	$15.1M	Buy	160,076 +16,463	+11%	+$1.43M	0.16%	140
2023 Q1	$11.9M	Sell	143,613 -78,417	-35%	-$6.16M	0.13%	174
2022 Q4	$16.6M	Sell	222,030 -30,625	-12%	-$2.36M	0.2%	141
2022 Q3	$20.9M	Sell	252,655 -30,156	-11%	-$2.9M	0.27%	110
2022 Q2	$26.9M	Buy	282,811 +259,009	+1,088%	+$26.8M	0.34%	69
2022 Q1	$2.8M	Buy	23,802 +23,024	+2,959%	+$2.58M	0.03%	360
2021 Q4	$101K	Sell	778 -22	-3%	-$2.57K	﹤0.01%	622
2021 Q3	$91K	Sell	800 -18	-2%	-$2.06K	﹤0.01%	558
2021 Q2	$85K	Sell	818 -268	-25%	-$25.3K	﹤0.01%	605
2021 Q1	$91K	Sell	1,086 -18,852	-95%	-$1.59M	﹤0.01%	587
2020 Q4	$1.82M	Sell	19,938 -189,192	-90%	-$15.7M	0.03%	422
2020 Q3	$16.7M	Sell	209,130 -11,220	-5%	-$875K	0.29%	85
2020 Q2	$15.2M	Buy	220,350 +24,693	+13%	+$1.75M	0.29%	82
2020 Q1	$12.3M	Buy	195,657 +110,571	+130%	+$7.97M	0.29%	85
2019 Q4	$6.62M	Buy	85,086 +2,817	+3%	+$220K	0.1%	219
2019 Q3	$6.03M	Sell	82,269 -13,035	-14%	-$916K	0.1%	230
2019 Q2	$5.87M	Sell	95,304 -1,335	-1%	-$80.7K	0.1%	229
2019 Q1	$6.16M	Sell	96,639 -52,134	-35%	-$2.98M	0.13%	189
2018 Q4	$7.6M	Buy	148,773 +123,888	+498%	+$6.27M	0.17%	162
2018 Q3	$1.44M	Buy	24,885 +11,184	+82%	+$547K	0.03%	487
2018 Q2	$665K	Buy	13,701 +981	+8%	+$45.8K	0.02%	648
2018 Q1	$591K	Buy	+12,720	New	+$552K	0.01%	671
2017 Q2	–	Sell	-2,373	Closed	-$74K	–	1148
2017 Q1	$74K	Sell	2,373 -1,917	-45%	-$60K	﹤0.01%	980
2016 Q4	$134K	Sell	4,290 -7,293	-63%	-$236K	﹤0.01%	923
2016 Q3	$465K	Buy	11,583 +3,213	+38%	+$121K	0.02%	294
2016 Q2	$279K	Sell	8,370 -3,051	-27%	-$104K	0.01%	388
2016 Q1	$336K	Sell	11,421 -12,969	-53%	-$358K	0.02%	337
2015 Q4	$642K	Buy	+24,390	New	+$633K	0.03%	289
2015 Q3	–	Sell	-830,070	Closed	-$19.7M	–	1145
2015 Q2	$19.7M	Buy	830,070 +233,076	+39%	+$5.26M	0.78%	30
2015 Q1	$14.2M	Sell	596,994 -21,354	-3%	-$479K	0.52%	58
2014 Q4	$13.1M	Buy	618,348 +268,524	+77%	+$5.39M	0.5%	59
2014 Q3	$5.96M	Buy	+349,824	New	+$5.52M	0.24%	121
2014 Q2	–	Sell	-1,800	Closed	-$22K	–	1073
2014 Q1	$22K	Buy	1,800 +108	+6%	+$1.25K	﹤0.01%	1050
2013 Q4	$19K	Buy	+1,692	New	+$19.1K	﹤0.01%	1057

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PineBridge Investments's EW Position: Q1 2026 in Review

PineBridge Investments increased its Edwards Lifesciences (EW) stake by 124% in Q1 2026, buying an estimated $383K and bringing the position to 8,390 shares worth $672K. The position accounts for 0.01% of the portfolio, ranked #413.

PineBridge Investments first reported a position in EW in Q4 2013 and has held it in 44 quarters since. The position peaked at $26.9M in Q2 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

PineBridge Investments held 8,390 shares of Edwards Lifesciences worth $672K as of Q1 2026.
PineBridge Investments bought 4,648 Edwards Lifesciences shares in Q1 2026, an estimated $383K.
Edwards Lifesciences made up 0.01% of PineBridge Investments's portfolio in Q1 2026, its #413 holding.
PineBridge Investments first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 44 quarters since.
PineBridge Investments's Edwards Lifesciences position peaked at $26.9M in Q2 2022.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on PineBridge Investments's 13F filing for Q1 2026, filed 14 May 2026.